Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × venetoclax × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 87 Leukemia, Lymphocytic, Chronic, B-Cell 42 Myelodysplastic Syndromes 27 Leukemia 15 Leukemia, Myelomonocytic, Chronic 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Burkitt Lymphoma 11 Recurrence 9 Lymphoma, Non-Hodgkin 8 Lymphoma, Mantle-Cell 8 Hematologic Neoplasms 8 Lymphoma 7 Leukemia, Biphenotypic, Acute 7 Neoplasms 6 Myeloproliferative Disorders 6 Lymphoma, Large B-Cell, Diffuse 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma, B-Cell 4 Waldenstrom Macroglobulinemia 3 Blastic Plasmacytoid Dendritic Cell Neoplasm 3 Anemia, Refractory, with Excess of Blasts 3 Primary Myelofibrosis 2 Lymphoproliferative Disorders 2 Lymphoma, Follicular 2 Leukemia, Myeloid 2 Immunoglobulin Light-chain Amyloidosis 2 Hematologic Diseases 2 Venentoclax 1

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡